Stockreport

Gamida Cell Announces Completion of Patient Enrollment in Ongoing Phase 3 Clinical Study of Omidubicel

Gamida Cell Ltd. - Ordinary Shares  (GMDA) 
Last gamida cell ltd. - ordinary shares earnings: 11/13 04:01 pm Check Earnings Report
PDF – Topline data expected in first half of 2020 – BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures [Read more]